发明名称 CARBAZOLE DERIVATIVES, SOLVATES THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF
摘要 <p num="1"><br/><br/>An object of the present invention is to provide novel carbazole derivatives, <br/>solvates thereof, or pharmaceutically acceptable salts thereof having an <br/>excellent <br/>adipose tissue weight reducing effect, hypoglycemic effect, and hypolipidemic <br/>effect, <br/>which are useful as a preventive and/or therapeutic agent for fatty liver, <br/>obesity, lipid <br/>metabolism abnormality, visceral adiposity, diabetes, hyperlipemia, impaired <br/>glucose <br/>tolerance, hypertension, non-alcoholic fatty liver disease, non-alcoholic <br/>steatohepatitis, and the like.<br/> The above-mentioned object can be achieved by carbazole derivatives, <br/>solvates thereof, or pharmaceutically acceptable salts thereof, wherein the <br/>carbazole <br/>derivatives are represented by the following general formula (I):<br/><br/>(see formula I) <br/>(In the formula (I), the ring A represents phenyl group or the like; X <br/>represents -O- or <br/>the like; Y represents =N- or the like; a and b represent methylene group or <br/>the like; <br/>both V and Z represent -O- or the like; W represents a C1-C10 alkylene group <br/>whose 1 <br/>or 2 hydrogen atoms may be substituted by a phenyl group or a C1-C6 alkyl <br/>group; <br/>1,2-phenylene group; 1,3-cyclohexyl group; or the like; R1 represents methyl <br/>group or <br/>the like; R2 represents methoxy group or the like; and R3 represents carboxy <br/>group or <br/>the like.)<br/><br/><br/>
申请公布号 CA2585642(C) 申请公布日期 2013.04.02
申请号 CA20052585642 申请日期 2005.10.28
申请人 ZERIA PHARMACEUTICAL CO., LTD. 发明人 MURATA, MASAKAZU;ITOKAZU, YOSHIHIKO;NAKAO, RYU
分类号 C07D413/12;A61K31/422;A61K31/427;A61K31/4439;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P9/12;A61P43/00;C07D413/14;C07D417/12 主分类号 C07D413/12
代理机构 代理人
主权项
地址